Luis M. Vilá to Disease Progression
This is a "connection" page, showing publications Luis M. Vilá has written about Disease Progression.
Connection Strength
0.954
-
Nieves-Plaza M, Ortiz AP, Col?n M, Molina MJ, Castro-Santana LE, Rodr?guez VE, Mayor AM, Vil? LM. Outcome and predictors of kidney disease progression in Puerto Ricans with systemic lupus erythematosus initially presenting with mild renal involvement. J Clin Rheumatol. 2011 Jun; 17(4):179-84.
Score: 0.325
-
Gonz?lez-Mel?ndez A, B?ez-Negr?n L, R?os-Rivera R, Franco-O'Connell AS, Nieves-Plaza M, Vil? LM. Short- and mid-term outcomes in systemic lupus erythematosus patients presenting with disease exacerbation after SARS-CoV-2 mRNA vaccination: A cohort study from Puerto Rico. Lupus. 2023 Apr; 32(4):571-579.
Score: 0.182
-
V?zquez-Otero I, Medina-Cintr?n N, Arroyo-?vila M, Gonz?lez-Sep?lveda L, Vil? LM. Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus. Lupus Sci Med. 2020 05; 7(1).
Score: 0.151
-
Santiago-Casas Y, Vil? LM, McGwin G, Cantor RS, Petri M, Ramsey-Goldman R, Reveille JD, Kimberly RP, Alarc?n GS, Brown EE. Association of discoid lupus erythematosus with clinical manifestations and damage accrual in a multiethnic lupus cohort. Arthritis Care Res (Hoboken). 2012 May; 64(5):704-12.
Score: 0.087
-
Pons-Estel GJ, Alarc?n GS, McGwin G, Danila MI, Zhang J, Bastian HM, Reveille JD, Vil? LM. Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort. Arthritis Rheum. 2009 Jun 15; 61(6):830-9.
Score: 0.071
-
Vil? LM, Alarc?n GS, McGwin G, Bastian HM, Fessler BJ, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual. Arthritis Rheum. 2006 Oct 15; 55(5):799-806.
Score: 0.059
-
Pons-Estel GJ, Alarc?n GS, Gonz?lez LA, Zhang J, Vil? LM, Reveille JD, McGwin G. Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort. Arthritis Care Res (Hoboken). 2010 Mar; 62(3):393-400.
Score: 0.019
-
Fern?ndez M, Alarc?n GS, McGwin G, Sanchez ML, Apte M, Vil? LM, Reveille JD. Using the Short Form 6D, as an overall measure of health, to predict damage accrual and mortality in patients with systemic lupus erythematosus: XLVII, results from a multiethnic US cohort. Arthritis Rheum. 2007 Aug 15; 57(6):986-92.
Score: 0.016
-
Fern?ndez M, Alarc?n GS, Apte M, Andrade RM, Vil? LM, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort: XLIII. The significance of thrombocytopenia as a prognostic factor. Arthritis Rheum. 2007 Feb; 56(2):614-21.
Score: 0.015
-
Andrade RM, Alarc?n GS, Fern?ndez M, Apte M, Vil? LM, Reveille JD. Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort. Arthritis Rheum. 2007 Feb; 56(2):622-30.
Score: 0.015
-
Alarc?n GS, McGwin G, Petri M, Ramsey-Goldman R, Fessler BJ, Vil? LM, Edberg JC, Reveille JD, Kimberly RP. Time to renal disease and end-stage renal disease in PROFILE: a multiethnic lupus cohort. PLoS Med. 2006 Oct; 3(10):e396.
Score: 0.015